As a 360° CDMO, Aenova offers all services from a single source:The combination of experience, quality, delivery reliability and cost efficiency.

Jan Kengelbach, CEO Aenova Group

As a leading contract manufacturer for numerous large pharmaceutical companies, Aenova must always ensure the supply of patients worldwide with sometimes vital medicines. The challenges of the pandemic in times of globalized commodity flows and supply chains are that, on the one hand, the active ingredients can either only be procured in Asia or - if they are produced in Europe - the precursors are often of Asian origin. In addition, in the highly regulated pharmaceutical market, many approvals only allow one source of raw materials, which further exacerbates the situation. However, our global procurement has so far coped very well with this stress test and has ensured very good supply with proactive risk management and permanent communication with all stakeholders.